Novel antifungal 2-aryl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivatives with high activity against Aspergillus fumigatus

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 16, 1996, Pages 2031-2036

  Dickinson, Roger P ^a   Bell, Andrew S ^a   Hitchcock, Christopher A ^a   Narayanaswami, Subramaniyan ^a   Ray, Stephen J ^a   Richardson, Kenneth ^a   Troke, Peter F ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,4 TRIAZOLE DERIVATIVE; ANTIFUNGAL AGENT; VORICONAZOLE;

ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

ANIMALIA; ASPERGILLUS FUMIGATUS; CANDIDA; ISSATCHENKIA ORIENTALIS;

EID: 0030594967     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00363-0     Document Type: Article

References (19)

1. (1) Como, A.C.; Dismukes, W.E. New Eng. J. Med. 1994, 330, 263-272.
2. (2) Karyotakis, N.C.; Anaissie, E.J. Curr. Opin. Inf. Dis. 1994, 7, 658-666.
3. (3) Zervos, M.; Meunier, F. Int. J. Antimicrob. Agents. 1993, 3, 147-170.
4. (4) Narayanaswami, S.; Richardson, K. Eur. Pat. 122,056; Chem. Astr. 1985, 102, 132,042.
5. (4) Narayanaswami, S.; Richardson, K. Eur. Pat. 122,056; Chem. Astr. 1985, 102, 132,042.
6. (5) Narayanaswami, S.; Richardson, K. Unpublished results.
7. (6) Richardson, K. UK Pat. 2,099,818,1982; Chem. Abstr. 1983, 99, 38467.
8. (6) Richardson, K. UK Pat. 2,099,818,1982; Chem. Abstr. 1983, 99, 38467.
9. (7) For evaluation of compounds in vitro, a series of agar plates, or liquid medium in microtiter plates, each having the test compound incorporated at a particular concentration, was inoculated with a standard culture of fungus, e.g. A. fumigatus, and each plate was then incubated for 48 hr. at 37°C. The plates were then examined for the presence or absence of growth of the fungus and the appropriate MIC was noted.
10. (8) Detailed X-ray crystallographic data for 24b and 30 have been deposited at the Cambridge Cristallographic Data Centre.
11. (9) Tasaka, A.; Tsuchimori, N.; Kitazaki, T.; Hiroe, K.; Hayashi, H.; Okonogi, K.; Itoh, K. Chem. Pharm. Bull. 1995, 43, 441-449.
12. (10) Jezequel, S.G., Pfizer Sandwich. Unpublished results.
13. 25 -62° (c = 1mg/ml in MeOH)
14. (12) Grant, S.M.; Clissold, S.P. Drugs 1990, 39, 877-916.
15. (13) Fisher, M.A.; Shen, S-H.; Haddad, J.; Tarry, W.F. Antimicrob. Agents Chemotherapy 1989, 33, 1443-1446
16. (14) Rozenberg-Arska, M.; Dekker, A.W.; Branger, J.; Verhoef, J. J. Antimicrob. Chemother. 1991, 27, 369-376.
17. (15) Wingard, J.R; Merz, W.G.; Rinaldi, M.G.; Johnson, T.R.; Karp, J.E.; Saral, R. New Eng. J. Med. 1991, 325, 1274-1277.
18. (16) Goodman, J.L. et al. New Eng. J. Med. 1992, 326, 845-851.
19. (17) Chandrasekar, P.H.; Gatny, C.M. J. Antimicrob. Chemother. 1994, 33, 309-318.